STD Diagnostics Market is Set for a Rapid Growth and is Expected to Reach USD 248.06 Billion by 2026

25-Sep-2018 | Zion Market Research

Zion Market Research has published a new report titled “STD Diagnostics Market by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, and Others), by Testing Devices (Laboratory Devices, and Point of Care Devices), and by End-User (Hospitals, and Others) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2026.” According to the report, the STD Diagnostics Market accounted for USD 141.96 Billion in 2019 and is expected to reach USD 248.06 Billion by 2026, growing at a CAGR of around 8.3% between 2020 and 2026.

Browse the full “STD Diagnostics Market by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing and Others) and by Testing Devices (Laboratory Devices and Point of Care Devices) for Hospitals and Other End Users - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2026” report at http://www.zionmarketresearch.com/report/std-diagnostics-market

Rising occurrence of weakened immune system to boost the STD diagnostics market
As per analysts at Zion Market Research, the STD diagnostics market was likely to see the highest development in the years to come due to rising percentage of HIV/HPV infected people all over the world. In addition to this, rising occurrence of weakened immune system paired with unsafe sex is also believed as a major driving reason that promotes sexually transmitted diseases and hence indirectly benefits the STD diagnostics market. Furthermore, rising demand for accurate and rapid diagnostic tests and attendance of favorable government programs for STD testing in emerging nations such as India, Brazil, and China are additionally claimed to propel the growth of STD diagnostics market.

On the other hand, the high price of diagnostic test is believed as a primary limiting factor that will hamper the development of STD diagnostics market. In addition to this, the discontinuation of therapy and reluctance of the infected population paired with the psychological effect of sexual transmitted are also believed as a major restraining factor that might hinder the development of STD diagnostics market.

New R&D activities by government and academic bodies are also set to drive the STD diagnostics market. For instance, in July 2018, a group of researchers have established a new defense against the virus that causes AIDS, HIV-1. The team employed an animal model to demonstrate that an antibody dubbed as IgM (Immunoglobulin M) was effective in stopping infection after exposure to mucosal AIDS virus.

Accessibility of technologically enhanced computer-directed screening tests led to the growth of STD diagnostics market in North America

Area-wise, North America was the dominating area for STD diagnostics market in 2019 in terms of income owing to the accessibility of technologically enhanced computer-directed screening tests. Europe and North America has the high occurrence of P&S Syphilis, Chlamydia, and Gonorrhea and holds the biggest share for testing in this region for these infections. In addition to this, lifestyle-associated factors such as having several sex partners, is very ordinary in European nations and the U.S. This led to the rise in the occurrence of sexually transmitted infection boosting the STD diagnostics market.

The key participants operating in the global STD diagnostics market are Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure.

The global STD diagnostics market is segmented as follows:

By Type 

  • Chlamydia testing
  • Syphilis testing
  • Gonorrhea testing
  • Herpes Simplex Virus testing
  • Human Papilloma Virus testing
  • Human Immunodeficiency Virus testing
  • Others

By End User 

  • Hospitals
  • Others

By Testing

  • Laboratory Devices
  • Point of Care Devices

By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social